Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
Status:
Completed
Trial end date:
2019-09-23
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if minocycline can reduce the side
effects reported by patients with NSCLC who are receiving chemoradiation therapy. In this
study, minocycline will be compared to a placebo.
Minocycline is an antibiotic that may help to reduce side effects of chemoradiation therapy.
A placebo is not a drug. It looks like the study drug but is not designed to treat any
disease or illness. It is designed to be compared with a study drug to learn if the study
drug has any real effect.